Editorial response to “Clinical complete response to neoadjuvant chemotherapy for muscle-invasive bladder cancer: contemporary outcomes of a multi-institutional cohort study”

The ultimate goal of cancer therapy is to cure the patient and restore a high quality of life. For patients with muscle invasive bladder cancer (MIBC), the ability to preserve the bladder is an important goal since it will avoid the complications of cystectomy and long-term negative implications on urinary and sexual function.